AI answers about pharma reputation never name CVS Health; Pfizer, Merck and J&J fill the gap

They don't. In this snapshot (measured 2026-09-28), CVS Health was not named in any of the 25 answers. That covers five benchmark questions, none of which named a brand, each put to ChatGPT, Claude, Gemini, Perplexity and Grok. Because nothing was said about CVS Health, this snapshot shows no way the assistants framed it.

The answers spent their space on other names. On trust, pricing and litigation, the answers centered on drug manufacturers. Pfizer appeared in 15 of the 25 answers, and Johnson & Johnson and Merck in 13 each. AbbVie appeared in 8 and Eli Lilly in 6. The trust answers also drew on outside rankings, and Perplexity's centered on Roche, Novartis, GSK, Bayer and Johnson & Johnson.

The patient-access and insurer questions opened the widest field. Even there, the assistants named other organizations. On patient access, Claude's answer credited UnitedHealth Group with specific steps on prior approval and rural hospital payments. Perplexity's answer listed Roche, Sanofi, UCB and others. On insurers, UnitedHealth Group was named by ChatGPT, Claude and Grok. Kaiser Permanente and Humana led the Claude and Perplexity answers. Gemini and Perplexity named no brand from this peer set on the insurer question.

Several answers also declined to name a winner at all. Perplexity opened its trust answer with "There is no single universal ranking of the “most trusted” pharmaceutical companies". When the assistants did name companies, CVS Health was not among them.

The PeakMetrics news index recorded 5,895 mentions of CVS Health over the last 30 days, and 1,158 of them carried the brand in the headline. Among the sector peers in this snapshot, only Moderna, at 10,024, and UnitedHealth Group, at 6,182, are anywhere near that range. The other peers run from 11,036 for AbbVie to 20,326 for Merck.

The recent headlines lean toward investor and shareholder storylines. One syndicated headline asks whether CVS Health Corporation insiders breached their fiduciary duties to shareholders, and it appears on several sites. Others compare Cardinal Health's dividend with CVS Health's, or set out reasons investors are bearish or bullish on the stock. That is what the sampled headlines show, not a full account of everything published about the company.

The press index shows CVS Health in the news at a scale close to UnitedHealth Group's. UnitedHealth Group was named in 4 of the 25 answers, while CVS Health was named in none. Moderna is in the same position: 10,024 news mentions and no naming in these answers.

The two stories are also about different things. The recent press headlines are about shareholders, dividends and stock sentiment. The assistant answers were built around trust surveys, pricing controversies, access indexes, litigation records and insurer satisfaction rankings. Nothing in the sampled headlines connects to those source types, and that may partly explain why coverage volume did not turn into a mention here. This snapshot cannot test that explanation.

This is one run. Live answers vary between runs, so treat the absence as a reading of this date, not a fixed position.

For a CVS Health comms team, the useful finding is where the answers drew their material. The trust and access answers leaned on named external indexes and surveys, including PatientView, the Access to Medicine Index, Caliber and Gallup. The insurer answers leaned on Insure.com, NCQA and J.D. Power. Those are the reference points the assistants reached for on these questions, and they were the basis for the names that appeared.

A practical next step is to run these benchmark questions again and add ones closer to how CVS Health describes itself. This snapshot used broad category questions, so it does not show whether the company appears when the question fits its business more closely. Track cited domains and share of citations alongside press volume, since the two measured different things here.